Selehold 45 mg spot-on solution for cats 2.6�7.5 kg
Selehold 45 mg spot-on solution for cats 2.6�7.5 kg
Authorised
This information is not available for this product.
Product identification
Medicine name:
Selehold 45 mg spot-on solution for cats 2.6�7.5 kg
Selehold 45 mg kožni nanos, raztopina za mačke od 2,6 do 7,5 kg
Active substance:
This information is not available for this product.
Target species:
-
Cat
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Spot-on use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovenia
Package description:
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 1 pipette.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 3 pipettes.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 6 pipettes.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 15 pipettes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- Krka d.d. Novo Mesto
- Tad Pharma GmbH
Responsible authority:
- Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
- DC/V/0639/007
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0394/002
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 11/02/2022
Slovenian (PDF)
Published on: 29/02/2024
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 29/02/2024
Labelling
This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 29/02/2024
How useful was this page?: